NCT01071681已完成不适用
Observational Survey Assessing the Factors of Treatment Intensification in Uncontrolled Hypertensive Patients Under a Combination Therapy, Either Fixed or Not, of a Renin-Angiotensin System Blocker (RASB) and Hydrochlorothiazide (HCTZ), According to Their Level of Cardiovascular Risk.
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Bayer
- 入组人数
- 1,589
- 主要终点
- Percentage of patients, according to the level of cardiovascular risk, who, at the end of the visit:- do not present any modification of hypertension treatment (therapeutic inertia) - present a change in the hypertension therapeutic
研究概览
简要总结
This study will describe the factors influencing the physician in face of elevated blood pressure in already treated patients
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Men or women over 18
- •Hypertensive patients
- •Uncontrolled hypertension (blood pressure >/=140/90 mmHg on the day of consultation or >/=130/80 mmHg in diabetic patients or in patients suffering from kidney failure, or in elderly patients with a systolic blood pressure >/=150 mmHg (in the absence of orthostatic hypotension)
- •Patients treated with a combination, fixed or not, of Renin-Angiotensin System Blocker (RASB) + Hydrochlorothiazide (HCTZ)
- •Patients examined in common medical care practice, whatever the reason for consultation
- •Patients informed of the study
排除标准
- 未提供
研究组 & 干预措施
Group 1
干预措施: Telmisartan (Kinzal/Pritor, BAY68-9291) (Drug)
结局指标
主要结局
Percentage of patients, according to the level of cardiovascular risk, who, at the end of the visit:- do not present any modification of hypertension treatment (therapeutic inertia) - present a change in the hypertension therapeutic
时间窗: on day 1
次要结局
- Analyses of the factors that had an impact on the therapeutic decision(on day 1)
研究者
相似试验
已完成
不适用
Ambulatory Blood Pressure and BehaviorCardiovascular DiseasesHeart DiseasesHypertensionNCT00005170National Heart, Lung, and Blood Institute (NHLBI)
已完成
不适用
Factors Predicting Blood Pressure Change With Interscalene BlockSystolic Blood Pressure (20% or Greater Increase)NCT06394960Konya City Hospital110
已完成
不适用
Analysis of factors associated with blood pressure reduction and serum potassium elevation in hypertensive patients treated with esaxerenone (CS-3150) -Integrated analysis from CS-3150 phase 3 studiesHypertensionJPRN-UMIN000047026Daiichi Sankyo Co., Ltd.1,472
已完成
Unknown
Analysis of factors associated with blood pressure reductions in hypertensive patients treated with esaxerenone -Integrated analysis from esaxerenone clinical studiesHypertensionJPRN-UMIN000051525Daiichi Sankyo Co., Ltd.493
招募中
不适用
Association Between Blood Pressure and Risk of PSCICognitive DeclineBlood PressureStrokeNCT06730711First Affiliated Hospital of Chongqing Medical University600